Enalapril

CHEMBL578 Phase 4 Zugelassen Small molecule
Half-Life
11 hours
Bioavailability
Protein Binding
Molecular Weight
376.4 g/mol
LogP
-0.1
Phase
4

This medication relaxes blood vessels by blocking an enzyme that produces a hormone called angiotensin II, making it easier for the heart to pump blood. It is widely used to treat high blood pressure and heart failure.

Molekularmasse

376,4470 g/mol

LogP

-0,10

TPSA

95,90 Ų

Lipinski-Regel der Fünf

Bestanden

Therapeutische Bereiche

Arzneimittelklassen

Wirkmechanismus

Prodrug converted to enalaprilat; inhibits ACE preventing angiotensin I to II conversion.

Pharmacokinetics (PK)

Half-Life 11 hours

Pharmacodynamics (PD)

Mechanismus

Prodrug converted to enalaprilat; inhibits ACE preventing angiotensin I to II conversion.

2D-Struktur

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O

InChI

InChI=1S/C20H28N2O5/c1-3-27-20(26)16(12-11-15-8-5-4-6-9-15)21-14(2)18(23)22-13-7-10-17(22)19(24)25/h4-6,8-9,14,16-17,21H,3,7,10-13H2,1-2H3,(H,24,25)/t14-,16-,17-/m0/s1

Molecular Formula

C20H28N2O5

HBD / HBA

2 / 6

Rotierbare Bindungen

10

Schwere Atome

27

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Häufig gestellte Fragen

This medication relaxes blood vessels by blocking an enzyme that produces a hormone called angiotensin II, making it easier for the heart to pump blood. It is widely used to treat high blood pressure and heart failure.

Prodrug converted to enalaprilat; inhibits ACE preventing angiotensin I to II conversion.

Key pharmacokinetic parameters for Enalapril: Half-life: 11 hours.

Yes, Enalapril is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

Related Drugs

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL578. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 5388962. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Medizinischer Haftungsausschluss

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.